A comprehensive single-cell map of T cell exhaustion-associated immune environments in human breast cancer
- PMID: 36609566
- PMCID: PMC9822999
- DOI: 10.1038/s41467-022-35238-w
A comprehensive single-cell map of T cell exhaustion-associated immune environments in human breast cancer
Abstract
Immune checkpoint therapy in breast cancer remains restricted to triple negative patients, and long-term clinical benefit is rare. The primary aim of immune checkpoint blockade is to prevent or reverse exhausted T cell states, but T cell exhaustion in breast tumors is not well understood. Here, we use single-cell transcriptomics combined with imaging mass cytometry to systematically study immune environments of human breast tumors that either do or do not contain exhausted T cells, with a focus on luminal subtypes. We find that the presence of a PD-1high exhaustion-like T cell phenotype is associated with an inflammatory immune environment with a characteristic cytotoxic profile, increased myeloid cell activation, evidence for elevated immunomodulatory, chemotactic, and cytokine signaling, and accumulation of natural killer T cells. Tumors harboring exhausted-like T cells show increased expression of MHC-I on tumor cells and of CXCL13 on T cells, as well as altered spatial organization with more immature rather than mature tertiary lymphoid structures. Our data reveal fundamental differences between immune environments with and without exhausted T cells within luminal breast cancer, and show that expression of PD-1 and CXCL13 on T cells, and MHC-I - but not PD-L1 - on tumor cells are strong distinguishing features between these environments.
© 2023. The Author(s).
Conflict of interest statement
B.B. is a co-founder of Navignostics, a precision oncology diagnostics company based on multiplexed tumor imaging. All other authors declare no competing interests.
Figures
References
-
- Robert C, et al. Durable complete response after discontinuation of pembrolizumab in patients with metastatic melanoma. J. Clin. Oncol. 2018;36:1668–1674. - PubMed
-
- Berghmans, T., Dingemans, A., Hendriks, L. E. L. & Cadranel, J. Immunotherapy for nonsmall cell lung cancer: a new therapeutic algorithm. Eur. Respir. J. 55, 1901907 (2020). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
